166 related articles for article (PubMed ID: 2481061)
1. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
Ivanov EP; Tsvirko DG
Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
[TBL] [Abstract][Full Text] [Related]
2. [Determination of fibrin-fibrinogen degradation products in the blood serum by an immunological method].
Andreenko GV; Liutova LB
Lab Delo; 1976; (4):206-8. PubMed ID: 66370
[No Abstract] [Full Text] [Related]
3. A rapid turbidimetric determination of fibrinogen degradation products (FDP).
Verbruggen HW; Wessels JM
Thromb Haemost; 1978 Feb; 39(1):12-21. PubMed ID: 580487
[TBL] [Abstract][Full Text] [Related]
4. [Determination of soluble complexes of fibrin monomers in plasma taking into consideration the fibrinogen level].
Ivanov EP; Tsvirko DG; Ivanov VE
Lab Delo; 1989; (12):38-43. PubMed ID: 2483201
[TBL] [Abstract][Full Text] [Related]
5. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
Lab Delo; 1978; (5):259-66. PubMed ID: 79007
[No Abstract] [Full Text] [Related]
6. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
7. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
[TBL] [Abstract][Full Text] [Related]
8. Laser nephelometry quantitation of fibrinogen-related antigens.
Ruiz-Arenas R; Lepe-Zuniga JL; Ruiz-Arguelles A; de Ruiz NL; Marin-Lopez A; Ruiz-Reyes G
Am J Clin Pathol; 1981 Sep; 76(3):284-8. PubMed ID: 7282628
[TBL] [Abstract][Full Text] [Related]
9. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
10. [Determination of coagulofibrinolytic factors by laser nephelometry (author's transl)].
Nakamura K; Tokuda M; Iijima K
Rinsho Byori; 1981; 29(7):655-61. PubMed ID: 7328798
[No Abstract] [Full Text] [Related]
11. [The estimation of fibrinogen by kinetic immunonephalometry].
Coquelin H; Mahdouani K; Boucaud-Maitre Y; Hutinel P; Cloppet H
Ann Biol Clin (Paris); 1982; 40(2):79-82. PubMed ID: 6751169
[TBL] [Abstract][Full Text] [Related]
12. A fully automated immuno-turbidimetric determination of fibrin(ogen) degradation products.
Hoak DR; Mammen EF; Banerjee SK; Kaldor G
Thromb Res; 1986 Oct; 44(1):1-10. PubMed ID: 3538493
[TBL] [Abstract][Full Text] [Related]
13. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative determination of fibrinogen and fibrin degradation products by means of immunodiffusion].
Paradeeva IK; Zhukova IV
Lab Delo; 1979; (10):590-2. PubMed ID: 94124
[No Abstract] [Full Text] [Related]
15. Immunonephelometric determination of fibrinogen on citrated or heparinized plasma: comparison with functional Clauss method.
Bargnoux AS; Dupuy AM; Biron-Andréani C; Schved JF; Cristol JP
Clin Lab; 2005; 51(5-6):285-8. PubMed ID: 15991802
[TBL] [Abstract][Full Text] [Related]
16. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
Kolodie L; Phelipp X; Baccard C
Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
[TBL] [Abstract][Full Text] [Related]
17. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
18. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
Chi DS; Chen JP
Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
[TBL] [Abstract][Full Text] [Related]
19. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
Wilmes EH; Hochstrasser K
Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
[TBL] [Abstract][Full Text] [Related]
20. [Determination of the fibrinogen/fibrin antigen content in the blood plasma and serum by radial immunodiffusion].
Iakunin GA; Smolianitskiĭ AIa; Kurguzova OP; Grabskiĭ MA
Lab Delo; 1982; (7):408-10. PubMed ID: 6181303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
